5-N-(1H-benzimidazol-2-yl)-4-N-[2-[[cyclohexyl(methyl)amino]methyl]phenyl]-1H-imidazole-4,5-dicarboxamide
C26H29N7O2 — CID 24985776
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-N-(1H-benzimidazol-2-yl)-4-N-[2-[[cyclohexyl(methyl)amino]methyl]phenyl]-1H-imidazole-4,5-dicarboxamide
5-N-(1H-benzimidazol-2-yl)-4-N-[2-[[cyclohexyl(methyl)amino]methyl]phenyl]-1H-imidazole-4,5-dicarboxamide (PubChem CID 24985776) has the molecular formula C26H29N7O2 and a molecular weight of 471.57 g/mol. Its IUPAC name is 5-N-(1H-benzimidazol-2-yl)-4-N-[2-[[cyclohexyl(methyl)amino]methyl]phenyl]-1H-imidazole-4,5-dicarboxamide.
Molecular Properties
| Compound Name | 5-N-(1H-benzimidazol-2-yl)-4-N-[2-[[cyclohexyl(methyl)amino]methyl]phenyl]-1H-imidazole-4,5-dicarboxamide |
|---|---|
| PubChem CID | 24985776 |
| Molecular Formula | C26H29N7O2 |
| Molecular Weight | 471.57 g/mol |
| Exact Mass | 471.24 |
| IUPAC Name | 5-N-(1H-benzimidazol-2-yl)-4-N-[2-[[cyclohexyl(methyl)amino]methyl]phenyl]-1H-imidazole-4,5-dicarboxamide |
| SMILES | CN(Cc1ccccc1NC(=O)c1nc[nH]c1C(=O)Nc1nc2ccccc2[nH]1)C1CCCCC1 |
| InChI | InChI=1S/C26H29N7O2/c1-33(18-10-3-2-4-11-18)15-17-9-5-6-12-19(17)29-24(34)22-23(28-16-27-22)25(35)32-26-30-20-13-7-8-14-21(20)31-26/h5-9,12-14,16,18H,2-4,10-11,15H2,1H3,(H,27,28)(H,29,34)(H2,30,31,32,35) |
| InChIKey | OVVWRSIGWDAEPM-UHFFFAOYSA-N |
| XLogP | 4.56 |
| TPSA | 118.80 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 471.57 |
| LogP ≤ 5 | 4.56 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 24985776 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.